Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 155.00 | 111.50 | 1.3901 | 1.4509 | |
| SK-BR-3 | 0 | uM | 8 | 156.25 | 36.27 | 69.00 | 111.50 | 0.6188 | 0.4873 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 278.00 | 311.75 | 0.8917 | 0.7299 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 295.00 | 311.75 | 0.9463 | 0.8649 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 312.50 | 180.33 | 391.00 | 311.75 | 1.2542 | 1.6644 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 312.50 | 180.33 | 280.00 | 311.75 | 0.8982 | 0.7457 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 312.50 | 180.33 | 296.00 | 311.75 | 0.9495 | 0.8729 |
| SK-BR-3 | Erlotinib | 1 | uM | 8 | 312.50 | 180.33 | 293.00 | 311.75 | 0.9399 | 0.8489 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 312.50 | 180.33 | 150.00 | 311.75 | 0.4812 | -0.2080 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 312.50 | 180.33 | 355.00 | 311.75 | 1.1387 | 1.3576 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 312.50 | 180.33 | 509.00 | 311.75 | 1.6327 | 2.7208 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 312.50 | 180.33 | 332.00 | 311.75 | 1.0650 | 1.1659 |
| SK-BR-3 | Lapatinib | 1 | uM | 8 | 312.50 | 180.33 | 214.00 | 311.75 | 0.6865 | 0.2420 |
| SK-BR-3 | Linsitinib | 10 | uM | 8 | 312.50 | 180.33 | 295.00 | 311.75 | 0.9463 | 0.8649 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 312.50 | 180.33 | 297.00 | 311.75 | 0.9527 | 0.8809 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 312.50 | 180.33 | 226.00 | 311.75 | 0.7249 | 0.3309 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 312.50 | 180.33 | 337.00 | 311.75 | 1.0810 | 1.2073 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 8 | 312.50 | 180.33 | 509.00 | 311.75 | 1.6327 | 2.7208 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 8 | 312.50 | 180.33 | 262.00 | 311.75 | 0.8404 | 0.6048 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 8 | 312.50 | 180.33 | 210.00 | 311.75 | 0.6736 | 0.2127 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 312.50 | 180.33 | 311.00 | 311.75 | 0.9976 | 0.9939 |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 373.00 | 311.75 | 1.1965 | 1.5100 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 8 | 312.50 | 180.33 | 292.00 | 311.75 | 0.9367 | 0.8409 |
| SK-BR-3 | Linsitinib | 1 | uM | 8 | 312.50 | 180.33 | 353.00 | 311.75 | 1.1323 | 1.3408 |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 270.00 | 311.75 | 0.8661 | 0.6671 |